In vitro percutaneous absorption enhancement of granisetron by chemical penetration enhancers

References

• Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW et al. (2005). Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer, 13:219–227.
   PubMed Web of Science ®Google Scholar
• Jantunen IT, Kataja VV, Muhonen TT. (1997). An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting. Eur J Cancer, 33:66–74.
   PubMed Web of Science ®Google Scholar
• Wester RC, Maibach HI. (1992). Percutaneous absorption of drugs. Clin Pharmacokinet, 23:253–266.
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Guy RH (eds) Transdermal Drug Delivery: Developmental Issues and Research Initiatives. New York: Marcel Dekker, 1989.
   Google Scholar
• Chaturvedula A, Joshi DP, Anderson C, Morris R, Sembrowich WL, Banga AK. (2005). Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery. Pharm Res, 22:1313–1319.
   PubMed Web of Science ®Google Scholar
• Jeong SW, Cho JW, Hwang JS, Song JD, Shin S, Jang JY et al. (2005). The antiemetic effect of a novel tropisetron patch in anticancer agents-induced kaolin pica model using rats. Environ Toxicol Pharmacol, 20:167–174.
   PubMed Web of Science ®Google Scholar
• Obata Y, Ashitaka Y, Kikuchi S, Isowa K, Takayama K. (2010). A statistical approach to the development of a transdermal delivery system for ondansetron. Int J Pharm, 399:87–93.
   PubMed Web of Science ®Google Scholar
• del Giglio A, Soares HP, Caparroz C, Castro PC. (2000). Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials. Cancer, 89:2301–2308.
   PubMed Web of Science ®Google Scholar
• Aapro M. (2004). Granisetron: an update on its clinical use in the management of nausea and vomiting. Oncologist, 9:673–686.
   PubMed Web of Science ®Google Scholar
• Jordan K, Hinke A, Grothey A, Schmoll HJ. (2005). Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a pooled analysis. Support Care Cancer, 13:26–31.
   PubMed Web of Science ®Google Scholar
• Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW et al. (1999). Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol, 17:2971–2994.
   PubMed Web of Science ®Google Scholar
• NCCN. Clinical Practice Guidelines in Oncology: Antiemesis, Ver1. Available at: http://www.nccn.org/professionals/physician_gls/PDF/antiemesis-Japanese.pdf. Accessed in 2005.
   Google Scholar
• Herrstedt J, Aapro MS, Roila F, Kataja VV; ESMO Guidelines Task Force. (2005). ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV). Ann Oncol, 16 Suppl 1:i77–i79.
   PubMed Web of Science ®Google Scholar
• Clarke SE, Austin NE, Bloomer JC, Haddock RE, Higham FC, Hollis FJ et al. (1994). Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica, 24:1119–1131.
   PubMed Web of Science ®Google Scholar
• Ranade VV. (1991). Drug delivery systems. 6. Transdermal drug delivery. J Clin Pharmacol, 31:401–418.
   PubMed Web of Science ®Google Scholar
• Johnson ME, Blankschtein D, Langer R. (1997). Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci, 86:1162–1172.
   PubMed Web of Science ®Google Scholar
• Lee CK, Uchida T, Kitagawa K, Yagi A, Kim NS, Goto S. (1994). Skin permeability of various drugs with different lipophilicity. J Pharm Sci, 83:562–565.
   PubMed Web of Science ®Google Scholar
• Woo JS. (2007). Nasal absorption studies of granisetron in rats using a validated high-performance liquid chromatographic method with mass spectrometric detection. Arch Pharm Res, 30:778–784.
   PubMed Web of Science ®Google Scholar
• Zheng WW, Zhao L, Wei YM, Ye Y, Xiao SH. (2010). Preparation and the in vitro evaluation of nanoemulsion system for the transdermal delivery of granisetron hydrochloride. Chem Pharm Bull, 58:1015–1019.
   PubMed Web of Science ®Google Scholar
• Barry BW. Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85–97.
   Google Scholar
• Sinha VR, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm, 26:1131–1140.
   PubMed Web of Science ®Google Scholar
• Zhao L, Fang L, Xu Y, Liu S, He Z, Zhao Y. (2008). Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers. Eur J Pharm Biopharm, 69:199–213.
   PubMed Web of Science ®Google Scholar
• Zhao L, Fang L, Xu Y, Zhao Y, He Z. (2008). Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity. Int J Pharm, 352:92–103.
   PubMed Web of Science ®Google Scholar
• Zhao L, Li Y, Fang L, He Z, Liu X, Wang L et al. (2009). Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation. Int J Pharm, 374:73–81.
   PubMed Web of Science ®Google Scholar
• Wen Z, Fang L, He Z. (2009). Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro. Drug Deliv, 16:214–223.
   PubMed Web of Science ®Google Scholar
• Fang L, Kobayashi Y, Numajiri S, Kobayashi D, Sugibayashi K, Morimoto Y. (2002). The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol Pharm Bull, 25:1339–1344.
   PubMed Web of Science ®Google Scholar
• Niazy EM. Differences in penetration-enhancing effect of Azone through excised rabbit, rat, hairless mouse, guinea pig and human skins. Int J Pharm 1996;130:225–230.
   Web of Science ®Google Scholar
• Scheuplein RJ. Site variations in diffusion and permeability. In: Jarret A, ed The Physiology and Pathophysiology of Skin. New York: Academic Press, 1978:1693–1730.
   Google Scholar
• Hansen CM. The three dimensional solubility parameter—key to paint component affinities. 1. Solvents, plasticisers, polymers and resins. J Paint Technol, 1976;39:104–117.
   Google Scholar
• Hansen CM. The three dimensional solubility parameter—key to paint component affinities. 2. Dyes, emulsifiers, mutual solubility and compatibility, and pigments. J Paint Technol, 1976;39:505–510.
   Google Scholar
• van Krevelen DW. Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions, 3rd ed. Amsterdam: Elsevier, 1990.
   Google Scholar
• Torres SP, Barjoan PD. Process for preparing a pharmaceutically active compound (granisetron) [P]. United States of America: US 7,071,209 B2, July 4, 2006.
   Google Scholar
• Izumoto T, Aioi A, Uenoyama S, Kuriyama K, Azuma M. (1992). Relationship between the transference of a drug from a transdermal patch and the physicochemical properties. Chem Pharm Bull, 40:456–458.
   PubMed Web of Science ®Google Scholar
• Monene LM, Goosen C, Breytenbach JC, Hadgraft J, du Plessis J. (2005). Percutaneous absorption of cyclizine and its alkyl analogues. Eur J Pharm Sci, 24:239–244.
   PubMed Web of Science ®Google Scholar
• Wang MY, Yang YY, Heng PW. (2005). Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent. Int J Pharm, 290:25–36.
   PubMed Web of Science ®Google Scholar
• Kikwai L, Kanikkannan N, Babu RJ, Singh M. (2002). Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J Control Release, 83:307–311.
   PubMed Web of Science ®Google Scholar
• Singh BN, Singh RB, Singh J. (2005). Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm, 298:98–107.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Ahmad N, Langer R, Mitragotri S, Prasad Shastri V. (2006). Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm, 308:33–39.
   PubMed Web of Science ®Google Scholar
• Leichtnam ML, Rolland H, Wüthrich P, Guy RH. (2006). Identification of penetration enhancers for testosterone transdermal delivery from spray formulations. J Control Release, 113:57–62.
   PubMed Web of Science ®Google Scholar
• Yamada M, Uda Y, Tanigawara Y. (1987). Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem Pharm Bull, 35:3399–3406.
   PubMed Web of Science ®Google Scholar
• Patrick IA, Beall HD, Gilroy P, Sloan KB. Effect of vehicles on topical delivery of 5-fluorouracil (5FU) by 1-acry-5FU prodrugs. Int J Pharm, 1997;154:39–48.
   Web of Science ®Google Scholar
• Wang MY, Yang YY, Heng PW. (2004). Role of solvent in interactions between fatty acids-based formulations and lipids in porcine stratum corneum. J Control Release, 94:207–216.
   PubMed Web of Science ®Google Scholar
• Dias M, Hadgraft J, Lane ME. (2007). Influence of membrane-solvent-solute interactions on solute permeation in skin. Int J Pharm, 340:65–70.
   PubMed Web of Science ®Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, York P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci, 88:1182–1190.
   PubMed Web of Science ®Google Scholar
• Marjukka Suhonen T, Bouwstra JA, Urtti A. (1999). Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release, 59:149–161.
   PubMed Web of Science ®Google Scholar
• Jonathan H. (2004). Skin deep. Eur J Pharm Biopharm, 2004;58:291–299.
   PubMed Web of Science ®Google Scholar
• Harrison JE, Groundwater PW, Brain KR, Hadgraft J. Azone induced fluidity in human stratum corneum. Afourier transform infrared spectroscopy investigation using the perdeuterated analogue. J Control Release, 1996;41:283–290.
   Web of Science ®Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–618.
   PubMed Web of Science ®Google Scholar
• Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. (1991). Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res, 8:350–354.
   PubMed Web of Science ®Google Scholar